Silence Therapeutics onboards J.P. Gabriel as CTOO
Silence Therapeutics plc, (“Silence” or “the Company”), One of the experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, recently announced the appointment of J.P. Gabriel as Chief Technical Operations Officer (CTOO) following the retirement of Jørgen Wittendorff, SVP, Technical Operations. In this role, J.P. is responsible […]
